Cigna Group — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Brian C. Evanko and CFO Ann M. Dennison certified the Q2 2026 10-Q (period ending June 30, 2026) filed July 30, 2026. Both officers certify that the report contains no untrue material facts, that financial statements fairly present the company's condition and results, and that disclosure controls and internal controls over financial reporting are effective. No changes, deficiencies, material weaknesses, or fraud are disclosed.
Why this rating
Routine Sarbanes-Oxley certification exhibits; standard periodic disclosure with no substantive business developments, transactions, or control issues reported.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.